Skip to site content

Increase in Pediatric Invasive Group A Streptococcal Infections

The Centers for Disease Control and Prevention (CDC) issued a Health Advisory to notify clinicians and public health authorities of a recent increase in pediatric invasive group A streptococcal (iGAS) infections. The rates of iGAS infections are increasing above cases reported during the COVID pandemic time period. Although the overall number of cases has remained relatively low and iGAS infections remain rare in children,the CDC is investigating these reports and issued a health advisory to raise awareness.

Group A Streptococcus (GAS) bacteria can cause a range of illnesses, from pharyngitis (i.e., strep throat) and skin and soft tissue infections to uncommon but severe diseases such as sepsis, streptococcal toxic shock syndrome, and necrotizing fasciitis. These severe and invasive diseases are associated with high mortality rates and require immediate treatment, including appropriate antibiotic therapy. Increased rates of iGAS infection have been noted during times of increased influenza activity. Seasonal influenza activity is currently high in the US and above the
levels seen in recent years.

Groups at higher risk for iGAS include:

  • People with concurrent or preceding viral infections
  • People aged 65 years or older
  • American Indian and Alaska Native populations
  • Residents of long-term care facilities
  • People with medical conditions such as diabetes, malignancy, immunosuppression, chronic kidney, cardiac, or respiratory disease
  • People with wounds or skin disease
  • People who inject drugs or who are experiencing homelessness

Recommendations for Healthcare Providers

For more information, please consult the complete CDC Health Advisory Exit Disclaimer: You Are Leaving .